◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Enveric Biosciences, Inc.

CIK: 890821 SIC: 2834
-
Revenue
$-8.77M
Net Income
-
Gross Margin
-
Op. Margin
$-14.81M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 11 annual reports available (2011 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
Research & Development $2.78M $2.78M $2.84M $7.25M $4.79M $174.08K
Selling General & Admin - - - - $20.50M $5.44M
Operating Income $-8.77M $-8.77M $-9.63M $-16.45M $-64.62M $-5.62M
Interest Expense - - - - $10.32K $445.25K
Other Income/Expense - $2.46K $66.21K $-814.38K $8.19M $1.25M
Income Before Tax $-8.77M $-8.77M $-9.57M $-17.26M $-56.43M $-6.86M
Income Tax Expense - - $8.93K $28.91K $-7.45M -
Net Income $-8.77M $-8.77M $-9.57M $-17.29M $-48.98M $-6.86M
Basic EPS nan -36.24 -19.04 -8.09 nan nan
Diluted EPS nan -36.24 -19.04 -8.09 nan nan
Basic Shares Outstanding 108K 335K 42K 2.2M - 5.8M
Diluted Shares Outstanding 108K 335K 42K 2.2M - -
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
Cash & Cash Equivalents $4.68M $2.24M $2.29M $17.36M $1.58M
Other Current Assets $259.22K $493.56K $1.29M $380.84K $700.71K
Total Current Assets $4.94M $2.73M $3.58M $17.74M $2.28M
Property Plant & Equipment $159.23K $305.78K $507.38K $294.43K -
Goodwill - - - $1.59M -
Intangible Assets - $42.18K $210.93K $6.92M $1.82M
Total Assets $5.10M $3.08M $4.30M $26.72M $4.10M
Accounts Payable $581.02K $521.75K $1.22M - -
Accrued Liabilities $237.50K $735.10K $1.08M $1.29M -
Other Current Liabilities $99.88K $232.89K $23.61K - -
Total Current Liabilities $918.40K $1.49M $2.34M $2.08M $681.25K
Total Liabilities - - - $4.41M $681.25K
Common Stock $10.62K $565.00 $27.39K $325.79K $100.95K
Retained Earnings $-114.85M $-106.07M $-96.50M $-60.74M $-11.76M
Total Stockholders Equity $4.18M $1.59M $1.96M $22.31M $3.42M
Total Liabilities & Equity $5.10M $3.08M $4.30M $26.72M $4.10M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
Net Income $-10.96M $-8.77M $-9.57M $-17.29M $-48.98M $-6.86M
Depreciation & Amortization $200.86K $200.86K $337.49K $343.98K $656.64K $120.87K
Stock-based Compensation $1.42M $827.32K $1.56M $2.15M - $1.98M
Operating Cash Flow $-14.81M $-8.14M $-7.73M $-14.09M $-11.46M $-3.89M
Capital Expenditure - - - $5.18K - -
Investing Cash Flow - - - $11.67K $2.19M $-44.14K
Stock Issued - - $2.29M - $21.61M $488.00K
Financing Cash Flow $19.93M $10.58M $7.67M $-1.34M $24.90M $5.53M
Net Change in Cash $5.10M $2.44M $-46.95K $-15.44M $15.78M $1.53M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Research & Development $402.42K - $2.41M -
Operating Income $-1.87M - $-6.58M -
Interest Expense - - - -
Other Income/Expense - - $2.56K -
Income Before Tax $-1.87M - $-6.58M -
Income Tax Expense - - - -
Net Income $-1.87M $-1.88M $-6.58M -
Basic EPS -10.81 - -35.74 -
Diluted EPS -10.81 - -35.74 -
Basic Shares Outstanding $313.24K - $226.40K -
Diluted Shares Outstanding $313.24K - $226.40K -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $3.76M $2.24M
Other Current Assets $407.95K $493.56K
Total Current Assets $4.17M $2.73M
Property Plant & Equipment $196.52K $305.78K
Intangible Assets - $42.18K
Total Assets $4.36M $3.08M
Accounts Payable $683.71K $521.75K
Other Current Liabilities - $232.89K
Total Current Liabilities $905.88K $1.49M
Common Stock $5.18K $565.00
Retained Earnings $-112.65M $-106.07M
Total Stockholders Equity $3.46M $1.59M
Total Liabilities & Equity $4.36M $3.08M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-1.87M $-1.88M $-6.58M -
Depreciation & Amortization $40.37K - $161.37K -
Stock-based Compensation - - $587.09K -
Operating Cash Flow - - $-6.36M -
Stock Issued - - - -
Financing Cash Flow - - $7.89M -
Net Change in Cash - - $1.52M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...